The effect of hydroxyethyl starch (HES) on hemostasis seems to be mini
mal when it is used in recommended amounts. A number of studies have i
nvestigated the effect of HES on platelet function when administered i
n vivo, but there has been no study investigating the effect on the is
olated platelet function when administered in vitro. A photometrical m
ethod to assess platelet function in platelet-rich plasma (approximate
ly 250 X 10(9) platelets/L) was used with platelet aggregation induced
using either collagen, epinephrine, adenosine diphosphate, or ristoce
tin. We found a dose-dependent decrease of platelet aggregation in vit
ro with either collagen or epinephrine, but not with adenosine diphosp
hate or ristocetin. However, the changes of HES on platelet aggregatio
n were detected only in doses larger than those routinely used in the
clinical setting. Therefore, we conclude that the influence of HES at
the recommended doses on initial platelet aggregation may not be clini
cally relevant. Implications: The effect of hydroxyethyl starch on pla
telet function and coagulation is discussed. This study showed no infl
uence on platelets in clinically relevant doses in an in vitro model.